Navigation Links
Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009
Date:7/25/2008

DETROIT, July 25 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (Amex: CPD) posted net sales for the first quarter of Fiscal 2009, ended June 30, 2008, of $108.3 million, as compared to $35.4 million for the corresponding period of Fiscal 2008. This represents an increase of 206% over the first quarter of Fiscal 2008. Pre-tax income grew to $14.6 million for the first quarter of Fiscal 2009 as compared to a pre-tax income of $9.6 million during the corresponding period of Fiscal 2008, while net income increased by 11% to $9.4 million in the first quarter of Fiscal 2009, as compared to $8.5 million in the first quarter of Fiscal 2008.

Daniel H. Movens, Caraco's Chief Executive Officer, said, "Our sales results for the first quarter are primarily due to sales of distributed products launched by the Company during the fourth quarter of Fiscal 2008 under the distribution and sale agreement with Sun Pharma and, to a lesser extent, sales of other products launched in Fiscal 2008 under the marketing agreements with Sun Pharma as well as growth in sales of our own manufactured products."

Mr. Movens added, "Though distributed products launched in fourth quarter Fiscal 2008, remained a significant driver of our sales, first quarter Fiscal 2009 had solid growth on our overall product line over the corresponding period of Fiscal 2008. We continue to work towards improved market share of both new and existing products."

"Our strategy remains to grow the business appropriately by utilizing all of our diverse paths of development. During Fiscal 2008, the weight of distributed product sales significantly increased. This trend will most likely continue on a short-term basis. Overall, we are pleased with the directio
'/>"/>

SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation from Board of Directors of Jitendra Doshi and Appointment of GP Singh Sachdeva
2. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Methimazole Tablets USP, 5 mg and 10 mg
3. Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31
4. Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP
5. Pennsylvania Governor Rendell Breaks Ground for Global Pharmaceutical Services Companys North American Headquarters
6. Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule
7. Anadys Pharmaceuticals to Report Second Quarter 2008 Financial Results
8. Sonus Pharmaceuticals Receives Favorable NASDAQ Decision
9. Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP
10. Jazz Pharmaceuticals Announces $26.0 Million Registered Direct Offering
11. Huifeng Bio-pharmaceutical Technology Inc. Announces Strategic Alliance with Premier Media Service Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... 2 NicOx S.A.,(NYSE Eur... agreement with,DSM for the commercial manufactur...I, active pharmaceutical ingredient). Naproxcinod ...rst compound in the,Cyclooxygenase-Inhibiting Nit...tory agents, which recently achieved positive resu...
(Date:12/2/2008)...stCall/ -- Cardiogenesis Corporation (Pink Sheets:...sed in the treatment of patients suffering from se...an medical device executive and an experienced pub... of the Company,s Board of Directors, increasing t...Cohen, 49, has over 25 years of executive experien...
(Date:12/2/2008)...ia/ -- WuXi PharmaTech (Cayman) Inc.,(NYSE: WX ...ical device,research and development outsourcing ...tates, today announced it will dedicate its Philad...ics testing, cell banking and cell therapy,servic...inue its U.S.,biologics manufacturing operations....
(Date:12/1/2008)...Trends Research Group, Inc. released its third Tr...his report runs parallel to two ongoing studies Bi... Canadian Nephrology . The report is based on the...hrologists from the UK, Germany, France, Italy, an...anemia and hyperphosphatemia. , , In the ES...
Breaking Biology Technology:NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 2NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 3NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 4Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors 2Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors 3WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services 2WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services 3WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services 4WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services 5European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTrends Report 2
Waukesha, Wis. RedPrairie Corporation , a supply chain technology solutions provider that enables business process transformation, announced today that 55 percent of the top 20 retailers use RedP
...Neurognostics, Inc. , a Wisconsin company speciali...I) products and services, has been honored with a ...tanding Achievements. , ,Last year Neurognostics r...ch (SBIR) Grant from the National Institutes of He...RI-based biomarkers in Parkinson,s disease. Neurog...
...following this column over the last few years know...low me to arrange information into tidy boxes in s...ke better sense out of the information for myself)...etterman, his show enlightened me about how lists ... same time. , ,In one of my companies, I even adap...
...right now. Media executives, mostly in denial, are...th well-branded 24/7 Web-based news sites and gene...re model is about to be changed. Here are the issu...ceive the conventional TV feed are no longer just ...e hundreds of gadgets and screens lying around any...
Other Biology Technology:Though Weakening, Biotech IPO Market Still Viable, Burril & Co. Says 2Though Weakening, Biotech IPO Market Still Viable, Burril & Co. Says 3Though Weakening, Biotech IPO Market Still Viable, Burril & Co. Says 4When TV surrenders to Web... 2When TV surrenders to Web... 3
(Date:12/2/2008)...tates that are at the highest risk of sustaining d...to the dangers posed by rising temperatures, accor... of climate change that has already significantly ...d has already had widespread ecological and hydrol...the United States will experience at least as much...
(Date:12/2/2008)..., , Sometimes physicists resort to tried and tr...lanck Institute for Metals Research, the Universit...ve constructed micromachines using the same trick ...here the masts and rigging of the sailing ship are...e way, the scientists link the valves, pumps and s...
(Date:12/1/2008)...tomic Energy Agency (IAEA) today called for increa...could bolster efforts aimed at pulling millions of...s use radiation to produce improved high-yielding ... as drought or flood, or that are resistant to cer...duction, the technique is safe, proven and cost-ef...
(Date:12/1/2008)... Stanford University,s Woods Institute for the Env...dlife Fundhas been awarded a two-year, $1.97 milli...n to develop a software program for mapping and ev...te marine ecosystems. , Called Marine InVEST (In...offs), the proposed software will give policymaker...
Breaking Biology News(10 mins):Most US organizations not adapting to climate change 2Most US organizations not adapting to climate change 3Ship-in-a-bottle kit on a microchip 2Ship-in-a-bottle kit on a microchip 3Nuclear science for food security 2Natural Capital Project to develop conservation software 2Coming soon 3A Self guided computer based depression treatment 5053 1Coming soon 3A Self guided computer based depression treatment 5053 2Coming soon 3A Self guided computer based depression treatment 5053 3Most Parents Are Unaware of Expanded CDC Flu Vaccination Recommendations 26746 1Most Parents Are Unaware of Expanded CDC Flu Vaccination Recommendations 26746 2Most Parents Are Unaware of Expanded CDC Flu Vaccination Recommendations 26746 3Most Parents Are Unaware of Expanded CDC Flu Vaccination Recommendations 26746 4Most Parents Are Unaware of Expanded CDC Flu Vaccination Recommendations 26746 5New Jersey Hospital to Pay 243 85 Million to Resolve Allegations of Inflating Charges to Obtain Higher Medicare Reimbursement 26743 1New Jersey Hospital to Pay 243 85 Million to Resolve Allegations of Inflating Charges to Obtain Higher Medicare Reimbursement 26743 2Age alone should not be used to determine whether to treat prostate cancer with hormones 26740 1Age alone should not be used to determine whether to treat prostate cancer with hormones 26740 2Age alone should not be used to determine whether to treat prostate cancer with hormones 26740 3
...tories researchers John Shelnutt and Yujiang Song ...ttaches to a cell through a new process that produ...search will appear as a paper in an upcoming issue...Int. Ed. In advance of publication, it is featured... , Sandia is a National Nuclear Security Adminis...
...developed by researchers at the University at Buff...vival of mice with human breast-cancer tumors and ... animals by more than 50 percent. , The antibody, ...an antigen known as TF-Ag, which aids the adhesion...tibody did not kill the cancer cells, it blocked s...
... chimpanzees and humans diverged from a common anc...cientists have identified a new way to pinpoint th...elative ?and make us uniquely human. The Proceedi...e study in its Nov. 13 online edition. , "We sha...ith chimps," explained Dr. Daniel Geschwind, princ...
...udy at the University of Minnesota, Extension food...since April with a water-based electrochemical act...pes out E. coli. , While electrolyzed water syste...f Russian scientists, is unique because it produce...tion or off-flavors when sprayed on food. The syst...
Other Biology News:Sandia researchers discover way to see how a drug attaches to a cell 2Antibody extends life of mice with breast cancer 2Unraveling where chimp and human brains diverge 2
Mouse monoclonal antibody to QPCT - glutaminyl-peptide cyclotransferase (glutaminyl cyclase)
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z35,347-7) or contact custom
Request Info
Designed for use with any of the Agencourt kits in tube format.
Biology Products: